Kevin N Sheth
Overview
Explore the profile of Kevin N Sheth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
429
Citations
11127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson I, Brigger H, Smith J, Peasley E, Champagne A, Littig L, et al.
AJNR Am J Neuroradiol
. 2025 Mar;
PMID: 40081846
Background And Purpose: Portable MRI (pMRI) has emerged as a cost-effective and accessible tool for the identification of white matter hyperintensities (WMH), an independent risk factor for stroke and dementia....
2.
Rousseau J, Weber J, Alhanti B, Saver J, Messe S, Schwamm L, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250548.
PMID: 40072434
Importance: Tenecteplase is an alternative to alteplase for emergency treatment of acute ischemic stroke. However, limited data are available comparing their clinical effectiveness in routine clinical practice. Objective: To compare...
3.
Wu K, Huo S, Rivier C, Torres-Lopez V, Sharma R, de Havenon A, et al.
medRxiv
. 2025 Mar;
PMID: 40061328
Background And Objectives: Polygenic susceptibility to hypertension and diabetes negatively impacts the clinical trajectory of ischemic stroke survivors. We hypothesize that polygenic susceptibility to hyperlipidemia (PSH) negatively impacts cholesterol control...
4.
Abou Karam G, Chen M, Zeevi D, Harms B, Berson E, Torres-Lopez V, et al.
Stroke
. 2025 Mar;
PMID: 40052269
Background: Prior studies on the clinical impact of intracerebral hemorrhage (ICH) location have used visual localization of hematomas to neuroanatomical structures. However, hematomas often cross neuroanatomical structure boundaries with inter-reviewer...
5.
Tran A, Desser D, Zeevi T, Abou Karam G, Zietz J, DellOrco A, et al.
Appl Sci (Basel)
. 2025 Mar;
15(1).
PMID: 40046237
Hematoma expansion (HE) is an independent predictor of poor outcomes and a modifiable treatment target in intracerebral hemorrhage (ICH). Evaluating HE in large datasets requires segmentation of hematomas on admission...
6.
Forman R, Xin X, Kim C, Kernan W, Sheth K, Krumholz H, et al.
J Hypertens
. 2025 Feb;
43(4):715-718.
PMID: 39995224
The objective of this report is to characterize BP control among patients six months post stroke and measure time to first visit. Patients were discharged from the Yale New Haven...
7.
Rivier C, Szejko N, Renedo D, Clocchiatti-Tuozzo S, Huo S, de Havenon A, et al.
Nat Commun
. 2025 Feb;
16(1):1261.
PMID: 39893209
Chronological age is an imperfect estimate of molecular aging. Epigenetic age, derived from DNA methylation data, provides a more nuanced representation of aging-related biological processes. We examine the bidirectional relationship...
8.
Demarais Z, Conlon C, Rivier C, Clocchiatti-Tuozzo S, Renedo D, Torres-Lopez V, et al.
Neurology
. 2025 Jan;
104(4):e210276.
PMID: 39889253
Background And Objectives: Type 2 diabetes mellitus (T2DM) is highly genetically determined, and polygenic susceptibility to T2DM (PSD) increases the risk of worse glycemic control and adverse vascular outcomes. Its...
9.
Lansberg M, Wintermark M, Chen H, Howard G, Cassarly C, Pauls Q, et al.
JAMA Neurol
. 2025 Jan;
82(3):220-227.
PMID: 39869342
Importance: In the Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke (ARCADIA) randomized clinical trial, anticoagulation did not prevent recurrent stroke among patients with a recent cryptogenic stroke...
10.